Disease Severity and Quality of Life Outcome Measurements in Patients With Keloids: A Systematic Review
Lyons AB, Peacock A, Braunberger TL, Viola KV, and Ozog DM. Disease Severity and Quality of Life Outcome Measurements in Patients With Keloids: A Systematic Review. Dermatol Surg 2019.
BACKGROUND: Keloids have been assessed by numerous methods and severity indices resulting in a lack of standardization across published research.
OBJECTIVE: This study aims to evaluate published keloid randomized controlled trials (RCTs) and identify the need for a gold standard of assessment.
METHODS AND MATERIALS: PubMed, MEDLINE, and Embase were searched for human RCTs on keloid treatment during a 10-year period. Eligible studies were English language RCTs reporting disease severity outcome measures after keloid treatments.
RESULTS: A total of 40 disease outcome measures were used in 41 included RCTs. Twenty-four (59%) of the included studies used more than one disease severity scale. The most frequently used outcome measures were the Vancouver Scar Scale (34%) (n = 14), followed by serial photography (24%) (n = 10). These were followed by adverse events and complications (20%) (n = 8), Visual Analogue Scale (12%) (n = 5), keloid dimensions (12%) (n = 5), and Patient and Observer Scar Assessment Scale (10%) (n = 4). Only one study reported quality of life outcomes.
CONCLUSION: There is wide variation in keloid outcome measures in the published literature. A standardized method of assessment should be implemented to reduce the disparities between studies and to better be able to compare the numerous treatment modalities.
ePub ahead of print